Loading
ThermoGenesis Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Xu Xiaochun, was filed 30 Apr 2020.
ThermoGenesis Holdings, Inc.: what insiders have been doing
ThermoGenesis Holdings, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at ThermoGenesis Holdings, Inc. has published a filing in the past twelve months. The most recent one dates from 9 July 2024.
Over the whole record (from 2016), the tally stands at 5 purchases and 2 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
36
Thresholds
n/a
Buy Volume
€15M
5 ops. · all time
Sell Volume
€563,860
2 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended December 2023 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$9.4M
Gross profitUS$1.9M20% margin
EBITDA-US$7.7M-82% margin
Net income-US$18M-153.4% margin
Valuation
P/Book0.0x
Beta14.73
Balance sheet & cash
Total debtUS$10.6M
Free Cash Flow-US$5.5M
Profitability & ownership
ROE-801.9%
ROA-25.5%
% institutions0.0%
Last declaration on 9 July 2024
Declarations36 total
7,894,737 shares@ €0.354933.7% of flowCommon StockSEC:0001437749-24-022423:0
4,113,158 shares@ €0.349217.3% of flowCommon StockSEC:0001437749-24-008468:0
600,000 shares@ US$1.02100.0% of flowCommon StockSEC:0000897069-23-001629:0
654,206 shares@ €1.0138.0% of flowCommon StockSEC:0001437749-23-027433:0
10,552,234 shares@ €0.2702100.0% of flowCommon StockSEC:0001437749-22-016295:0
621,637 shares@ US$1.80Common StockSEC:0001437749-20-009025:0
683,824 sharesCommon StockSEC:0001437749-20-009028:0
683,824 sharesCommon StockSEC:0001437749-20-009028:1
Canonical exit: 25 Mar 2020 (T+90)
1,666,670 shares@ US$1.80Common StockSEC:0001437749-20-002957:0
683,824 sharesCommon StockSEC:0001437749-20-000189:0
Canonical exit: 25 Mar 2020 (T+90)
683,824 sharesCommon StockSEC:0001437749-20-000189:1
Canonical exit: 25 Mar 2020 (T+90)
35,000 sharesCommon StockSEC:0001437749-18-016607:0
35,000 shares@ US$0.18Common StockSEC:0001437749-18-016408:0
Canonical exit: 26 Nov 2018 (T+90)
4,080 shares@ US$3.17Common StockSEC:0001437749-17-012176:1
9,320 shares@ US$3.17100.0% of flowCommon StockSEC:0001437749-17-012176:0
162 shares@ US$3.15Common StockSEC:0001437749-17-005651:0
2,338 shares@ US$3.15Common StockSEC:0001437749-17-005651:1
25,000 shares@ US$2.89100.0% of flowCommon StockSEC:0001437749-17-003401:0
6,102,942 shares@ US$2.52Common StockSEC:0001683168-16-001026:0
Canonical exit: 26 Mar 2017 (T+90)
502 shares@ US$3.98Common StockSEC:0001437749-16-039317:0
3,000 shares@ US$4.00Common StockSEC:0001437749-16-039317:1
6,102,941 shares@ US$3.40Common StockSEC:0001437749-16-038049:0
12,997 shares0Common StockSEC:0001437749-16-035865:0
29,720 shares0Common StockSEC:0001437749-16-035864:0
15,734 shares0Common StockSEC:0001437749-16-035863:0
25 of 36 declarations
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. is a company focused on developing cell therapy solutions and biological products. It concentrates on applications in regenerative medicine and transplantation.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
